Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Dec 19, 2023

BUY
$7.36 - $11.17 $110,503 - $167,706
15,014 New
15,014 $163,000
Q4 2022

Feb 15, 2023

SELL
$7.36 - $11.17 $25,082 - $38,067
-3,408 Reduced 18.5%
15,014 $164,000
Q3 2022

Nov 15, 2022

BUY
$7.86 - $11.71 $144,796 - $215,721
18,422 New
18,422 $155,000
Q2 2020

Aug 17, 2020

SELL
$6.19 - $18.84 $18,217 - $55,446
-2,943 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$5.4 - $9.22 $232 - $396
43 Added 1.48%
2,943 $21,000
Q4 2019

Feb 14, 2020

BUY
$4.69 - $13.45 $13,601 - $39,005
2,900 New
2,900 $20,000

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.